TY - JOUR
T1 - Poor Outcomes of Patients With NAFLD and Moderate Renal Dysfunction or Short-Term Dialysis Receiving a Liver Transplant Alone
AU - Fernández-Carrillo, Carlos
AU - Li, Yaming
AU - Ventura-Cots, Meritxell
AU - Argemi, Josepmaria
AU - Dai, Dongling
AU - Clemente-Sánchez, Ana
AU - Duarte-Rojo, Andres
AU - Behari, Jaideep
AU - Ganesh, Swaytha
AU - Jonassaint, Naudia L.
AU - Tevar, Amit D.
AU - Hughes, Christopher B.
AU - Humar, Abhinav
AU - Molinari, Michele
AU - Landsittel, Douglas P.
AU - Bataller, Ramon
N1 - Funding Information:
RB was supported by NIH/NIAAA grants AA026972, AA026978 and AA026264 and NIDDK grant P30DK120531. CF-C and AC-S were supported by a grant from the Asociación Española para el Estudio del Hígado (AEEH).
Publisher Copyright:
Copyright © 2022 Fernández-Carrillo, Li, Ventura-Cots, Argemi, Dai, Clemente-Sánchez, Duarte-Rojo, Behari, Ganesh, Jonassaint, Tevar, Hughes, Humar, Molinari, Landsittel and Bataller.
PY - 2022/12/9
Y1 - 2022/12/9
N2 - The outcomes of patients with moderate renal impairment and the impact of liver disease etiology on renal function recovery after liver transplant alone (LTA) are largely unknown. We explored whether NAFLD patients with pre-LTA moderate renal dysfunction (GFR 25–45 ml/min/1.73 m2) may be more susceptible to develop post-LTA severe renal dysfunction (GFR<15 ml/min/1.73 m2) than ALD patients, as well as other overall outcomes. Using the UNOS/OPTN database, we selected patients undergoing liver transplant for NAFLD or ALD (2006–2016), 15,103 of whom received LTA. NAFLD patients with moderate renal dysfunction were more likely to develop subsequent GFR<15 ml/min/1.73 m2 than ALD patients (11.1% vs. 7.38%, p < 0.001). Patients on short-term dialysis pre-LTA (≤12 weeks) were more likely to develop severe renal dysfunction (31.7% vs. 18.1%), especially in NAFLD patients, and were more likely to receive a further kidney transplant (15.3% vs. 3.7%) and had lower survival (48.6% vs. 50.4%) after LTA (p < 0.001 for all). NAFLD was an independent risk factor for post-LTA severe renal dysfunction (HR = 1.2, p = 0.02). NAFLD patients with moderate renal dysfunction and those receiving short-term dialysis prior to LTA are at a higher risk of developing subsequent severe renal dysfunction. Underlying etiology of liver disease may play a role in predicting development and progression of renal failure in patients receiving LTA.
AB - The outcomes of patients with moderate renal impairment and the impact of liver disease etiology on renal function recovery after liver transplant alone (LTA) are largely unknown. We explored whether NAFLD patients with pre-LTA moderate renal dysfunction (GFR 25–45 ml/min/1.73 m2) may be more susceptible to develop post-LTA severe renal dysfunction (GFR<15 ml/min/1.73 m2) than ALD patients, as well as other overall outcomes. Using the UNOS/OPTN database, we selected patients undergoing liver transplant for NAFLD or ALD (2006–2016), 15,103 of whom received LTA. NAFLD patients with moderate renal dysfunction were more likely to develop subsequent GFR<15 ml/min/1.73 m2 than ALD patients (11.1% vs. 7.38%, p < 0.001). Patients on short-term dialysis pre-LTA (≤12 weeks) were more likely to develop severe renal dysfunction (31.7% vs. 18.1%), especially in NAFLD patients, and were more likely to receive a further kidney transplant (15.3% vs. 3.7%) and had lower survival (48.6% vs. 50.4%) after LTA (p < 0.001 for all). NAFLD was an independent risk factor for post-LTA severe renal dysfunction (HR = 1.2, p = 0.02). NAFLD patients with moderate renal dysfunction and those receiving short-term dialysis prior to LTA are at a higher risk of developing subsequent severe renal dysfunction. Underlying etiology of liver disease may play a role in predicting development and progression of renal failure in patients receiving LTA.
KW - acute kidney injury
KW - alcohol-related liver disease
KW - chronic kidney disease
KW - liver transplantation
KW - non-alcoholic steatohepatitis
UR - http://www.scopus.com/inward/record.url?scp=85144635634&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85144635634&partnerID=8YFLogxK
U2 - 10.3389/ti.2022.10443
DO - 10.3389/ti.2022.10443
M3 - Article
C2 - 36568138
AN - SCOPUS:85144635634
SN - 0934-0874
VL - 35
JO - Transplant International
JF - Transplant International
M1 - 10443
ER -